GMPR
Basic information
Region (hg38): 6:16238587-16295549
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GMPR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 5 |
Variants in GMPR
This is a list of pathogenic ClinVar variants found in the GMPR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-16238700-C-G | not specified | Uncertain significance (Aug 10, 2021) | ||
6-16238700-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
6-16238710-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
6-16238729-C-A | not specified | Uncertain significance (May 01, 2022) | ||
6-16238749-C-T | not specified | Uncertain significance (Apr 11, 2023) | ||
6-16246908-G-A | not specified | Uncertain significance (May 08, 2024) | ||
6-16246950-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
6-16250323-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
6-16250335-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
6-16250348-A-C | not specified | Uncertain significance (Oct 05, 2023) | ||
6-16254571-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
6-16254601-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
6-16254625-G-T | not specified | Uncertain significance (May 03, 2023) | ||
6-16254707-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
6-16254730-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
6-16274423-C-T | Benign (Dec 14, 2017) | |||
6-16274479-A-G | not specified | Uncertain significance (Jul 15, 2021) | ||
6-16278826-C-T | not specified | Uncertain significance (May 14, 2024) | ||
6-16278873-A-G | not specified | Uncertain significance (Sep 28, 2021) | ||
6-16278885-A-G | not specified | Uncertain significance (Mar 23, 2023) | ||
6-16285833-T-G | not specified | Uncertain significance (Jun 08, 2022) | ||
6-16290511-G-A | Benign (Dec 14, 2017) | |||
6-16290530-T-A | GMP REDUCTASE POLYMORPHISM | Benign (Jul 13, 2018) | ||
6-16290542-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
6-16290550-G-C | not specified | Uncertain significance (Aug 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GMPR | protein_coding | protein_coding | ENST00000259727 | 9 | 56970 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000131 | 0.849 | 124906 | 7 | 835 | 125748 | 0.00335 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.124 | 198 | 203 | 0.976 | 0.0000118 | 2249 |
Missense in Polyphen | 92 | 95.911 | 0.95922 | 1071 | ||
Synonymous | -0.575 | 89 | 82.4 | 1.08 | 0.00000552 | 688 |
Loss of Function | 1.39 | 10 | 16.0 | 0.624 | 7.55e-7 | 199 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000474 | 0.000474 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0249 | 0.0194 |
Finnish | 0.00365 | 0.00366 |
European (Non-Finnish) | 0.00309 | 0.00309 |
Middle Eastern | 0.0249 | 0.0194 |
South Asian | 0.000663 | 0.000588 |
Other | 0.00439 | 0.00424 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides. {ECO:0000255|HAMAP-Rule:MF_03195}.;
- Pathway
- Purine metabolism - Homo sapiens (human);Purine Nucleoside Phosphorylase Deficiency;Mercaptopurine Action Pathway;Azathioprine Action Pathway;Xanthine Dehydrogenase Deficiency (Xanthinuria);Adenylosuccinate Lyase Deficiency;AICA-Ribosiduria;Thioguanine Action Pathway;Adenine phosphoribosyltransferase deficiency (APRT);Mitochondrial DNA depletion syndrome;Myoadenylate deaminase deficiency;Purine Metabolism;Molybdenum Cofactor Deficiency;Adenosine Deaminase Deficiency;Gout or Kelley-Seegmiller Syndrome;Lesch-Nyhan Syndrome (LNS);Xanthinuria type I;Xanthinuria type II;Metabolism of nucleotides;Metabolism;Nucleotide salvage;Purine salvage;Purine nucleotides nucleosides metabolism
(Consensus)
Recessive Scores
- pRec
- 0.219
Intolerance Scores
- loftool
- 0.480
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 31.93
Haploinsufficiency Scores
- pHI
- 0.174
- hipred
- Y
- hipred_score
- 0.565
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.882
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gmpr
- Phenotype
Gene ontology
- Biological process
- purine nucleobase metabolic process;response to cold;purine ribonucleotide interconversion;purine-containing compound salvage;oxidation-reduction process
- Cellular component
- cytosol;GMP reductase complex
- Molecular function
- GMP reductase activity;metal ion binding